Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
58
VRE Quote, Financials, Valuation and Earnings
Last price:
$16.22
Seasonality move
:
13.97%
Day range:
$16.06 - $16.48
52-week range:
$13.84 - $18.85
Dividend yield:
1.59%
P/E ratio:
--
P/S ratio:
6.17x
P/B ratio:
1.39x
Volume:
418.2K
Avg. volume:
449.5K
1-year change:
11.13%
Market cap:
$1.5B
Revenue:
$271.1M
EPS (TTM):
-$0.24
Veris Residential Number of Institutional Trades
Veris Residential Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$924M
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$2.7B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Veris Residential Institutional Ownership
-
What Percentage Of VRE Is Owned by Institutions?
-- of VRE is owned by institutions.
-
How Many Institutions Own VRE Shares?
Veris Residential stock is owned by 432 institutional shareholders at this time.
-
Have Institutions Been Buying VRE Stock?
Yes, institutions have bought 24.4M shares of VRE in the last quarter.
-
Have Institutions Been Selling VRE Stock?
Yes, institutions have sold 96.1M shares of VRE over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
